Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy.
第一作者:
Björn Engelbrekt,Wahlin
第一单位:
Department of Medicine at Huddinge, Division of Hematology, Karolinska Institutet and The Hematology Center, Karolinska University Hospital , Stockholm , Sweden.
作者:
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗原, CD20(Antigens, CD20);丹麦(Denmark);女(雌)性(Female);芬兰(Finland);人类(Humans);淋巴瘤, 滤泡性(Lymphoma, Follicular);男(雄)性(Male);中年人(Middle Aged);多元分析(Multivariate Analysis);挪威(Norway);前瞻性研究(Prospective Studies);随机对照试验(主题)(Randomized Controlled Trials as Topic);存活率分析(Survival Analysis);瑞典(Sweden);治疗结果(Treatment Outcome);世界卫生组织(World Health Organization);青年人(Young Adult)
DOI
10.3109/10428194.2013.802778
PMID
23662992
发布时间
2019-01-16
- 浏览111

Leukemia & lymphoma
288-95页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文